IssuerAnnouncementDetailsV2Portlet
Actions
Correction announcement from Jamjoom Pharmaceuticals Factory Co. in regards to its Announcement on the Results of the Extraordinary General Assembly Meeting (First Meeting)
| Element List | Explanation |
|---|---|
| Date of Publishing the Previous Announcement Sought to be Corrected on Saudi Exchange’s Website | 2024-03-13 Corresponding to 1445-09-03 |
| Hyperlink to the Previous Announcement | Click Here |
| Incorrect statements in the previous announcement | The mistake occurred in the English text under item 19 of the Voting Results of the General Assembly's Meeting Agenda: Vote on amending Article (38) of the Company’s Bylaws which relates to the Expiration of the Company. |
| Correct Statement | Amending the English text under Item 19 of the Voting Results of the General Assembly's Meeting Agenda: Approval to amend Article (38) of the Company’s Bylaws which relates to the Expiration of the Company. |
| Additional Information | Results of the General Assembly's Meeting Agenda: after amendment in English (attached) |
| Attached Documents |  |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 0.0
Net Change 0.0 (0.0%)
Value Traded (Sar) 0
Volume Traded 0
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions